TAMPA, Fla. – Moffitt Cancer Center researchers launched a study to learn more about electronic cigarette, or e-cigarette, use in Florida. E-cigarettes are rapidly growing in popularity, with sales expected to reach $2 billion this year. Instead of burning tobacco, the devices vaporize a solution containing nicotine. While e-cigarettes are widely available, the quality and safety of the devices are largely unknown.
Moffitt researchers, in collaboration with the USF Health, created an online survey to learn more about why smokers choose e-cigarettes, how they use the devices and what they consider the advantages and disadvantages of e-cigarettes compared to regular cigarettes or nicotine products, such as nicotine gum or patches.
Some participants who complete the online survey will be invited to participate in a focus group about the devices.
Although there is debate in the public health community about the potential positive and negative impacts of e-cigarettes on the nation’s health, Thomas H. Brandon, Ph.D., chair of the Department of Health Outcomes and Behavior at Moffitt, says, “We are not taking any position on the value of e-cigarettes at this time. It is premature to judge until more information is known. Other researchers are studying the content and safety of the vapor inhaled by users. Here at Moffitt, we first want to better understand the perspective of the user.”
The online survey takes about 15 minutes to complete and all responses will be kept confidential.
About Moffitt Cancer Center
Located in Tampa, Moffitt is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, its contributions to clinical trials, prevention and cancer control. Since 1999, Moffitt has been listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer. With more than 4,200 employees, Moffitt has an economic impact on the state of nearly $2 billion. For more information, visit MOFFITT.org, and follow the Moffitt momentum on Facebook, twitter and YouTube.